Femoral Fracture Clinical Trial
Official title:
Prospective First in Human Clinical Investigation to Evaluate the Safety of the Fracture Monitor T1 in Patients With Femur Fractures Treated With a Locking Compression Plate
NCT number | NCT05410587 |
Other study ID # | FM_AO_001 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | October 3, 2023 |
Est. completion date | July 2025 |
Thirty-seven patients diagnosed with femoral fracture to be treated with a compatible plate will be enrolled for this multicenter prospective interventional study. The Fracture Monitor T1 will be attached to the locking plate during osteosynthesis. Prior to discharge, it will be connected to an app installed either on the patients' smartphone or on the smartphone provided by the sponsor. The device will continuously collect and process data, which can automatically be downloaded via Bluetooth through the smartphone app and transferred in encrypted form to a dedicated cloud server. The smartphones will be equipped with a basic app version with rudimentary user interface that has no data visualization function. During the rehabilitation phase, data collected by the device will not be accessible to the surgeon nor the patient to ensure that no therapeutic decision will be made based on the acquired data. Every patient is treated as per standard of care. The primary objective of the study is to collect safety information of the Fracture Monitor T1. The secondary objectives are to collect information on device performance, device handling, and usability. All adverse events (AEs) and serious AEs (SAEs) will be recorded during the study. These will be reviewed and evaluated for their potential relationship to the device. All patients will be followed up for 6 months after the surgery according to the local standard of care. Given that the removal of the Fracture Monitor T1 may occur beyond 6 months, a safety follow-up will take place at the time point when the Fracture Monitor T1 is removed as per the instructions for use if it has not been removed within the 6 months. The results will be compiled into a clinical evaluation report to be submitted as part of the technical documentation for the conformity assessment procedure.
Status | Recruiting |
Enrollment | 37 |
Est. completion date | July 2025 |
Est. primary completion date | October 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age 18 years or older - Closed growth plates at time of injury - Femoral fracture requiring osteosynthesis and treated with one of the following plates: - DePuy Synthes LCP® 4.5/5, Broad - DePuy Synthes LCP® 4.5/5, Broad Curved - DePuy Synthes LCP® Condylar Plate 4.5/5.0 - DePuy Synthes VA-LCP® Condylar Plate 4.5/5.0 - DePuy Synthes LCP® Distal Femur - DePuy Synthes LCP® Proximal Femoral Plate 4.5/5.0 - DePuy Synthes LCP® Proximal Femur Hook Plate - 41medical AG, Biphasic Plate DF - ASA score 1-3 - Full weight-bearing capacity prior to the injury - The patient is foreseen to be capable of postoperative weight bearing of at least 15 kg - Willingness to undergo an additional surgery to remove the Fracture Monitor T1 if its removal is not done together with the fixation plate within two years according to standard of care - Ability to provide written informed consent Preoperative exclusion Criteria: - Concomitant fractures in the contralateral leg - Electromagnetic hypersensitivity - Implanted electromagnetic bone stimulators - Pregnancy (determined by pregnancy test) - Prisoner - Known history of substance abuse (eg, recreational drugs and alcohol) that would preclude reliable assessments - Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present clinical investigation Intraoperative exclusion criteria: - Use of compression lag screw across fracture fragment - Compression osteosynthesis - Precontouring of implant at the area of the attachment of Fracture Monitor T1 - Double-plating technique - Soft-tissue coverage > 6 cm above the data logger - Concurrent use of intramedullary nail - Patients foreseen to require magnetic resonance imaging scanning at any part of the body or shockwave therapy at the proximity of the Fracture Monitor T1 - Fracture Monitor T1 not functional according to the instruction for use (IFU, section 24, A) and no functional replacement implant available |
Country | Name | City | State |
---|---|---|---|
Germany | Universitätsklinikum des Saarlandes | Homburg | |
Germany | Universitätsklinikum Münster | Münster | |
Germany | Berufsgenossenschaftliche Unfallklinik Tübingen | Tübingen | |
Germany | Universitätsklinikum Ulm | Ulm |
Lead Sponsor | Collaborator |
---|---|
AO Innovation Translation Center |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of ADEs | To evaluate the safety, (ie the incidence of adverse device effects (ADEs), of the investigational device Fracture Monitor T1 in femoral fracture patients) | 6 months postsurgery | |
Secondary | Clinical performance: Relationship - implant load/bone healing | Relationship between relative implant load and bone healing status | 6 months | |
Secondary | Clinical performance: Relationship - implant load/weight bearing | Relationship between relative implant load and prescribed weight bearing | 6 months | |
Secondary | Clinical performance: Relationship - implant load/Function Index for Trauma(FIX-IT) | Relationship between relative implant load and Function Index for Trauma (FIX-IT) score FIX-IT: max 12 points - 0 worse/12 best | 6 months | |
Secondary | Clinical performance: Relationship - implant load/Patient reported outcomes | Relationship between relative implant load and Patient reported outcomes: pain, EuroQol 5- dimension (EQ-5D) EQ-5D health states can be summarised using a 5-digit code or represented by a single summary number (index value) which reflects how good or bad a health state is according to the preferences of the general population of a country/region. | 6 months | |
Secondary | Clinical performance: Relationship - implant load/Modified Radiographic union score for tibia(mRUST) | Relationship between relative implant load and mRUST score. mRUST: The mRUST score ranges from 4-16 as the four cortices assessed in two orthogonal planes have a score range from 1 to 4 (1: absent callus - 4 callus remodeled) | 6 months | |
Secondary | Clinical performance: Curve drop | Analyses of the loading curve drop based on:
-Time to curve drop |
6 months | |
Secondary | Clinical performance: Difference curve drop/soc x-ray | Analyses of the loading curve drop based on:
Difference in the timing between drop in the loading curve (50%) and standard-of-care x-ray |
6 months | |
Secondary | Other safety parameters: AEs | - Incidence of adverse events (AEs) | 6 months | |
Secondary | Other safety parameters: DD | - Incidence of device deficiencies within 6 months | 6 months | |
Secondary | Technical performance in a clinical setup | • Average minimum sensor strain per loading event | 6 months | |
Secondary | Technical performance in a clinical setup | • Daily active time of implant (patient activity triggers recording of implant) | 6 months | |
Secondary | Technical performance in a clinical setup | • Number of daily activations (implant switches from idle to recording) | 6 months | |
Secondary | Technical performance in a clinical setup | • User calibration range (patient-specific calibration on stiffness of fixation construct) | 6 months | |
Secondary | Technical performance in a clinical setup | • Data down and upload frequency | 6 months | |
Secondary | Technical performance in a clinical setup | • Number of Bluetooth adverts | 6 months | |
Secondary | Technical performance in a clinical setup | • Bluetooth signal strength (dBm) | 6 months | |
Secondary | Technical performance in a clinical setup | • Bluetooth connection time (s) | 6 months | |
Secondary | Technical performance in a clinical setup | • Battery voltage after each month | 6 months | |
Secondary | Technical performance in a clinical setup | • Power consumption (device lifetime) | 6 months | |
Secondary | Technical performance in a clinical setup | • Internal device temperature | 6 months | |
Secondary | Technical performance in a clinical setup | • Initialization and daily system test results | 6 months | |
Secondary | Technical performance in a clinical setup | • Internal clock accuracy | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05515718 -
Effect of the Early Ultrasound-guided Femoral Nerve Block Performed by Emergency Physicians on Pre-operative Opioids Usage in Patients With Proximal Femoral Fractures
|
N/A | |
Recruiting |
NCT04494672 -
A Study to Verify if the Surgery for the Proximal Femur Fracture Can be Improved With the Help of a Navigation System
|
N/A | |
Unknown status |
NCT01680120 -
Dose Finding Study for Continuous Spinal Anaesthesia
|
Phase 4 | |
Recruiting |
NCT04015128 -
A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT
|
||
Recruiting |
NCT04015154 -
A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF
|
||
Recruiting |
NCT05276674 -
ZNN Bactiguard Retrograde Femoral Nails PMCF Study
|
||
Completed |
NCT02983344 -
Analgesia For Positioning Patient With Femur Fracture For Spinal Anaesthesia
|
N/A | |
Terminated |
NCT00764959 -
Retrospective Study of the Linear™ Hip
|
Phase 4 | |
Completed |
NCT02069327 -
The Role of Fat Emboli in the Trauma Inflammatory Response
|
||
Completed |
NCT03856502 -
Influence of Intrathecal Dexamethasone Administration for Proximal Femoral Fractures
|
N/A | |
Recruiting |
NCT05559736 -
Artemis Proximal Femoral Nail for Internal Fixation of Intertrochanteric Femur Fractures
|
N/A | |
Completed |
NCT03810092 -
Analysis of the Relationship Between Early Postoperative Anemia and the Evolution of Autonomy at 6 Months in Patients 75 Years of Age and Older Operated on Following a Fracture of the Upper End of the Femur
|
||
Recruiting |
NCT05087667 -
Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) )
|
N/A | |
Recruiting |
NCT05523635 -
Post Market Clinical Evaluation of Gamma 4
|
||
Recruiting |
NCT05274022 -
Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture
|
N/A | |
Terminated |
NCT01300520 -
The Development of a Surgical Localizing Aid Medical Device
|
N/A | |
Terminated |
NCT01141894 -
Goal Directed Haemodynamic Treatment for Patients With Proximal Femoral Fracture
|
N/A | |
Recruiting |
NCT05668182 -
A Case Series: TRUMATCH Graft Cage for Segmental Long Bone Defects
|
||
Recruiting |
NCT05680987 -
Retrograde Femoral Nail-Advanced Outcomes for Fixation of Distal Femur and Femoral Shaft Fractures
|
N/A | |
Not yet recruiting |
NCT04918680 -
Prospective Post-market Study Examining the Effectiveness of the EcoFit®
|